Study: J&J Vaccine 66% Effective Against COVID-19

Right now the Johnson and Johnson COVID-19 vaccine is on pause in the U.S. because of concerns over a possible link to rare cases of blood clots.

Video Transcript

- A new clinical study shows the Johnson and Johnson vaccine is about 66% effective against moderate to severe COVID-19, and that also includes variants. It's the same number the company released earlier this year. Right now, the Johnson and Johnson COVID-19 vaccine is on pause in the US because of concerns over a possible link to rare cases of blood clots.